Entain Marks Its First Day With Measures To Deliver On Its New Strategy
- U.S. growth accelerates as BetMGM plans to double its footprint in three months - Entain to seek licence in...
News
Abivax Establishes Clinical, Regulatory and Manufacturing Framework for ABX464 Phase 3 Program and Potential Commercialization in 2021
Pivotal ABX464 clinical trials ongoing or planned for three indications: Ulcerative colitis, Crohn's disease and Covid-19 Four phase 1 studies...
American Society of Mechanical Engineers Names Houston-based Medistar Corporation 2020 Emerging Technology Award Recipient for Inventing Integrated Viral Protection Air Filtration Systems to Stop Indoor Spread of COVID-19
HOUSTON--(BUSINESS WIRE)--#ASME--The American Society of Mechanical Engineers (ASME) has named Medistar Corporation as one of five 2020 Emerging Technology Award...
CPSI And QliqSOFT Announce Partnership to Provide CPSI Customers With COVID-19 Vaccination Assistance
QliqSOFT Chatbot Technology to Power COVID-19 Vaccination Administration Support MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--CPSI (NASDAQ: CPSI), a community healthcare solutions company, and...
Limitless Venture Group, Inc. Continues Its Expansion into the $250 Billion Dollar MGU/TPA Industry with A Strategic Partnership
TULSA, OK / ACCESSWIRE / December 9, 2020 / (OTC PINK:LVGI) Limitless Venture Group, Inc. ("LVGI" or "the Company") today...
CEO Jeff Comer Shares Tips for Effective Business Management
CAVE CREEK, AZ / ACCESSWIRE / December 9, 2020 / Dr. Jeff Comer, a successful leader in the Alaska healthcare...
Adial Pharmaceuticals CEO Weighs in on the Alcohol Pandemic and Drunk Driving Over the Holidays; FOX31 Denver’s Shaul Turner Interviews Bill Stilley
CHARLOTTESVILLE, VA / ACCESSWIRE / December 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...
Nationwide Medication Savings Leader Prescription Hope Maintains Full Operational Capacity During COVID-19
STUART, FL / ACCESSWIRE / December 9, 2020 / Prescription Hope, one of the largest patient assistance program administrators in...
Leafbuyer Technologies Inc. Announces Positive Cash Flow
Company Achieves Rare Milestone in Cannabis Industry DENVER, CO / ACCESSWIRE / December 9, 2020 / Leafbuyer Technologies, Inc. ("Leafbuyer"...
9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)
aGvHD among potential indications being considered for next stage of development Candidate to move to IND-enabling studies in 2021 RALEIGH,...
Chemesis International Inc. Announces Partnership with the RESET Group
The Companies will work together to bring Chemesis' AI retail solution to Portland, Oregon VANCOUVER, BC / ACCESSWIRE / December...
Grapefruit USA, Inc. Announces Execution of New License Agreement with Zylö Therapeutics Inc. Expanding Grapefruit’s Patented Hourglass Product line to include Hemp-Derived CBD Topical Delivery Creams For Nationwide Distribution
Powered by Zylö's patented Xerogel Silica Gel ("Z-Pod™") delivery system, Grapefruit's Patented Hourglass™ THC + Cannabinoid Topical Cream is the...
CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020
Broad and deep portfolio of highly differentiated product candidates aligned with needs of patients and doctorsRobust pipeline includes 4 development...
Telo Genomics Presents at ASH 2020 The Results of Hodgkin’s Lymphoma Clinical Study
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...
Amunix Presents Preclinical Data on AMX-818, a Protease-Activated HER2-Targeted T Cell Engager Prodrug, at SABCS 2020
– Data demonstrate potential of Amunix’s XPAT (XTENylated Protease-Activated T cell engager) platform to mitigate on-target, off-tumor toxicity that has...
Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with unrivaled OS evidence1Kisqali plus endocrine therapy had...
BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®
Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint...
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in Healthy Volunteers and in Newly Diagnosed COVID-19 Patients
FDA has granted clearance for the commencement of Phase 1 clinical trials of STI-2020 (COVI-AMGTM) in healthy volunteers and COVID-19...
Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer
–EDP1908 announced as clinical candidate in oncology after showing superior preclinical activity over EDP1503––Interim clinical data for EDP1503 suggest potential...